Insights and examples of how collaborative efforts can lead to the development of innovative therapies that target unmet patient needs.
Bertrand Ducrey
Advertisement
Bertrand Ducrey, Ph.D., is the CEO of Debiopharm, a Swiss-based global biopharmaceutical company.
Articles by Bertrand Ducrey
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
FDA Approves Lisraya for Adults with Dermatomyositis, Bixlenvo for Virologically Suppressed Adults with HIV, Mounjaro to Reduce MACE in Adults with Type 2 Diabetes
3
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
4
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
5